The global prescription dermatology therapeutics market will grow at a remarkable rate due to the increasing prevalence of chronic diseases such as psoriasis and other dermatological disorders. Introduction of new and innovative products across the globe to treat skin-related disorders is also expected to drive the market. This newly added report provides an unbiased and an in-depth analysis of the report to the clients. The report also offers a company market share analysis to give a wide overview of the prescription dermatology therapeutics market.
Global Prescription Dermatology Therapeutics Market: Key Players
Some of the major players operating in the global prescription dermatology therapeutics market are Aurobindo Pharma Ltd, AbbVie, Inc., Aclaris Therapeutics, Inc., Novartis AG, Sun Pharmaceuticals Ltd., Janssen Biotech, Inc., Bausch Health Companies, Inc., Amgen, Eli Lilly and Company, Celgene Corporation, LEO Pharma A/S, and Pfizer, Inc.
Global Prescription Dermatology Therapeutics Market: Drivers and Restraints
Skin is vulnerable to a broad variety of skin toxins and microbes. It is the most and the largest exposed organ of the body. Continuous exposure to toxins results in several kinds of skin diseases such as psoriasis, redness, and acne. Acne treatment is on the most important prescriptions used for improving skin conditions. For instance, psoriasis, a chronic skin disease, is caused by an overactive immune system. Light therapy, oral medications, and steroid creams are mostly used to treat psoriasis diseases.
The market is mainly driven by intensive research to provide therapies for dermatological disorders. Factors such as huge investments in the research and development activities by the pharmaceutical companies, rising urban population affected with the dermatological disorders, efforts taken by key players to provide effective treatments, and the strategic alliances by the companies to enhance the product development are likely to propel the growth of the market in the coming years.
However, the high cost of treatment and stringent government regulations for the approval of the dermatology drugs may create a negative impact on the growth of the prescription dermatology therapeutics market.
Get PDF template of this report: https://www.qyrconsulting.com/request-sample/7245
Global Prescription Dermatology Therapeutics Market: Forecast by Segments
The prescription dermatology therapeutics market is segmented on the basis of distribution channel and type.
By Distribution
- Mail order pharmacies
- Hospital pharmacies
- Retail pharmacies
The hospital pharmacies segment is expected to dominate the market in the near future due to the rising rate of hospitalization and the high cost of biologic drugs.
By Type
- Skin cancer
- Acne and rosacea drugs
- Fungal infection drugs
- Psoriasis drugs
- Seborrhea drugs
- Dermatitis
Psoriasis drugs held the largest market share in global market. The segment is expected to continue its dominance over the forecast period.
By Region
North America is likely to hold the largest market share in the global prescription dermatology therapeutics market due to high prevalence of chronic skin diseases and growing adoption of biological drugs for the treatments. Higher awareness as compared to other regions is also expected to boost the growth of this regional market. Asia Pacific is also expected to expand at significant rate due to growing awareness about skin disorders in the emerging economies such as India and China.
Global Prescription Dermatology Therapeutics Market: Competitive Landscape
Companies are expected to look at mergers and acquisitions as a way forward in the global prescription dermatology therapeutics market. For instance, Aurobindo Pharma Ltd. andSandoz Inc. have agreed that the former will take over latter’s dermatology and oral solids business. This move will make Aurobindo the second largest players distributing generics in the U.S. by prescriptions. This will also enable diversification of the portfolio, adding about 300 products, which includes the ones under development.
Report TOC, Figures and Tables: https://www.qyrconsulting.com/reports/global-prescription-dermatology-therapeutics-market
Table of Contents
Overview of the Report: The report starts with research scope, major players studied by the authors, years considered for the research study, objectives of the study, and analysis of market share by application and market size growth rate by type.
Global Growth Trends: Here, the size of the global Bio-pharma market is studied along with sales and revenue analysis. This section also includes industry trends and analysis of the growth rate of the global Bio-pharma market by region.
Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of revenue, sales, and share in the global Bio-pharma market.
Company Profiles: Almost all leading companies operating in the global Bio-pharma market are profiled in this section, taking into account their recent developments, market share, and other vital factors.
Market Forecast: Apart from revenue and sales forecast of the global Bio-pharma market, this section provides forecast of all
About Us:
We established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.
Contact US
QYR Consulting
17890 Castleton, Suite 218,
Los Angeles, CA – 91748
USA: +1 626 428 8800
China: +86 1082 945 717
Japan: +81 9038 009 273
India: +91 9766 478 224
Emails – sales@qyrconsulting.com
Web – https://www.qyrconsulting.com
